David Lawrence
2017
In 2017, David Lawrence earned a total compensation of $999.5K as Chief, Business Operations and Principal Accounting Officer at Acorda Therapeutics, a 27% decrease compared to previous year.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $102,651 |
| Option Awards | $145,582 |
| Salary | $391,083 |
| Stock Awards | $302,225 |
| Other | $7,950 |
| Total | $999,491 |
Lawrence received $391.1K in salary, accounting for 39% of the total pay in 2017.
Lawrence also received $50K in bonus, $102.7K in non-equity incentive plan, $145.6K in option awards, $302.2K in stock awards and $8K in other compensation.
Rankings
In 2017, David Lawrence's compensation ranked 8,976th out of 14,666 executives tracked by ExecPay. In other words, Lawrence earned more than 38.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,976 out of 14,666 | 39th |
Division Manufacturing | 3,434 out of 5,772 | 41st |
Major group Chemicals And Allied Products | 1,171 out of 2,075 | 44th |
Industry group Drugs | 935 out of 1,731 | 46th |
Industry Biological Products, Except Diagnostic Substances | 165 out of 313 | 47th |
Source: SEC filing on April 27, 2018.
Lawrence's colleagues
We found five more compensation records of executives who worked with David Lawrence at Acorda Therapeutics in 2017.
2017
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2017
Andrew Hindman
Acorda Therapeutics
Chief Business Officer
2017
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2017
Burkhard Blank
Acorda Therapeutics
Chief Medical Officer
2017
Jane Wasman
Acorda Therapeutics